Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Two vascular networks-the blood system and the lymphatic system-are required for maintaining tissues in a healthy state. In their Perspective, Jain and Padera discuss new work (Abtahianet al.) that identifies two signaling molecules involved in the separation of the blood and lymphatic networks during embryonic development.
The authors are at the Edwin L. Steele Laboratory of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. E-mail: jain{at}steele.mgh.harvard.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
REPORTS
Farhad Abtahian, Anastasia Guerriero, Eric Sebzda, Min-Min Lu, Rong Zhou, Attila Mocsai, Erin E. Myers, Bin Huang, David G. Jackson, Victor A. Ferrari, Victor Tybulewicz, Clifford A. Lowell, John J. Lepore, Gary A. Koretzky, and Mark L. Kahn (10 January 2003) Science299 (5604), 247.
[DOI: 10.1126/science.1079477] |Abstract »|Full Text »|PDF »|Supporting Online Material »
Reversible transdifferentiation of blood vascular endothelial cells to a lymphatic-like phenotype in vitro.
L. S. Cooley, M. M. Handsley, Z. Zhou, M. A. Lafleur, C. J. Pennington, E. W. Thompson, E. Poschl, and D. R. Edwards (2010)
J. Cell Sci.
123, 3808-3816
|Abstract »|Full Text »|PDF »
Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells.
G. Narazaki, H. Uosaki, M. Teranishi, K. Okita, B. Kim, S. Matsuoka, S. Yamanaka, and J. K. Yamashita (2008)
Circulation
118, 498-506
|Abstract »|Full Text »|PDF »
The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer.
O Camara, M Rengsberger, A Egbe, A Koch, M Gajda, U Hammer, C Jorke, C Rabenstein, M Untch, and K Pachmann (2007)
Ann. Onc.
18, 1484-1492
|Abstract »|Full Text »|PDF »
Toward a Systems Engineering Approach to Cancer Drug Delivery.
M. R. Dreher and A. Chilkoti (2007)
J Natl Cancer Inst
99, 983-985
|Full Text »|PDF »
Lymphatic Neoangiogenesis in Human Kidney Transplants Is Associated with Immunologically Active Lymphocytic Infiltrates.
D. Kerjaschki, H. M. Regele, I. Moosberger, K. Nagy-Bojarski, B. Watschinger, A. Soleiman, P. Birner, S. Krieger, A. Hovorka, G. Silberhumer, et al. (2004)
J. Am. Soc. Nephrol.
15, 603-612
|Abstract »|Full Text »|PDF »
Angiogenesis and Lymphangiogenesis in Tumors: Insights from Intravital Microscopy.
